Back to Trades
Total Value
$41.4K
Filing Date
Dec 3, 2025
1 transactions
Trade Summary
On Dec 2, 2025, Golden Lee Scott, Director, reported $41.4K of Cadrenal Therapeutics, Inc. (CVKD) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $8.27. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cadrenal Therapeutics, Inc.
- Ticker Symbol
- CVKD
- CIK
- 0001937993
Insider Information
- Name
- Golden Lee Scott
- Role
- Director
- Location
- PONTE VEDRA, FL
Filing Details
- Filing Date
- Dec 3, 2025
- Transaction Date
- Dec 2, 2025
- Accession Number
- 0001213900-25-118003
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 2, 2025 | CVKD derivative | 5,000 | $8.27 | Grant/Award | $41.4K |
Want live alerts when Golden Lee Scott trades again?
Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Consists of options to purchase 5,000 shares of common stock, which shall vest 1/3 on January 1, 2027 and thereafter pro rata on a monthly basis over 24 months, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.